News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Solvay Pharmaceuticals, Inc.'s Operating Results of EUR 616 Million for the 1st Half of 2007, Exceeding the Excellent Results for the 1st half of 2006
July 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, BELGIUM--(MARKET WIRE)--Jul 27, 2007 -- The full press release is available on http://www.solvay-investors.com/
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Rare diseases
Rare Disease Sales To Soar to $400B+ By 2032 as Small Molecules Resurgent: Evaluate
March 13, 2026
·
2 min read
·
Tristan Manalac
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
March 12, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds
March 12, 2026
·
35 min read
·
BioSpace Editorial Staff
Weight loss
Lilly Flags ‘Concerning’ Impurities in Compounded Tirzepatide
March 12, 2026
·
2 min read
·
Tristan Manalac
